Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma.

Seifart C, Lin HM, Seifart U, Plagens A, DiAngelo S, von Wichert P, Floros J.

Clin Genet. 2005 Aug;68(2):128-36.

PMID:
15996209
2.

Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.

Gautschi O, Hugli B, Ziegler A, Bigosch C, Bowers NL, Ratschiller D, Jermann M, Stahel RA, Heighway J, Betticher DC.

Lung Cancer. 2006 Mar;51(3):303-11. Epub 2006 Jan 10.

PMID:
16406195
3.

Surfactant protein B gene variations enhance susceptibility to squamous cell carcinoma of the lung in German patients.

Seifart C, Seifart U, Plagens A, Wolf M, von Wichert P.

Br J Cancer. 2002 Jul 15;87(2):212-7.

4.

Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.

Rosell R, Calvo R, Sánchez JJ, Maurel J, Guillot M, Monzó M, Núñez L, Barnadas A.

Clin Cancer Res. 1999 Jul;5(7):1849-54.

5.

Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer.

Jiang F, Caraway NP, Nebiyou Bekele B, Zhang HZ, Khanna A, Wang H, Li R, Fernandez RL, Zaidi TM, Johnston DA, Katz RL.

Clin Cancer Res. 2005 Aug 1;11(15):5417-24.

6.

[Transcriptional activity of surfactant-apoproteins A1 and A2 in non small cell lung carcinomas and tumor-free lung tissues].

Stoffers M, Goldmann T, Branscheid D, Galle J, Vollmer E.

Pneumologie. 2004 Jun;58(6):395-9. German.

PMID:
15216431
7.

Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.

Jack DL, Cole J, Naylor SC, Borrow R, Kaczmarski EB, Klein NJ, Read RC.

Clin Infect Dis. 2006 Dec 1;43(11):1426-33. Epub 2006 Oct 31.

PMID:
17083016
8.

Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.

Shih CM, Lee YL, Chiou HL, Chen W, Chang GC, Chou MC, Lin LY.

Lung Cancer. 2006 Apr;52(1):15-20. Epub 2006 Feb 14.

PMID:
16476505
9.

Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.

Suzuki T, Matsuo K, Hiraki A, Saito T, Sato S, Yatabe Y, Mitsudomi T, Hida T, Ueda R, Tajima K.

Carcinogenesis. 2007 Aug;28(8):1718-25. Epub 2007 Apr 29.

PMID:
17468511
10.

Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.

Zhai R, Liu G, Zhou W, Su L, Heist RS, Lynch TJ, Wain JC, Asomaning K, Lin X, Christiani DC.

Clin Cancer Res. 2008 Jan 15;14(2):612-7. doi: 10.1158/1078-0432.CCR-07-1655.

11.

Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?

Yaylim I, Isbir T, Oztürk O, Turna A, Işitmangil T, Zonüzi F, Camlica H.

Cancer Genet Cytogenet. 2002 Apr 15;134(2):118-22.

PMID:
12034523
12.

The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.

Kotsinas A, Evangelou K, Sideridou M, Kotzamanis G, Constantinides C, Zavras AI, Douglass CW, Papavassiliou AG, Gorgoulis VG.

Cancer Lett. 2008 Feb 8;259(2):177-85. Epub 2007 Nov 26.

PMID:
18037232
14.

An investigation of the relationship between SULT1A1 Arg(213)His polymorphism and lung cancer susceptibility in a Turkish population.

Arslan S, Silig Y, Pinarbasi H.

Cell Biochem Funct. 2009 Jun;27(4):211-5. doi: 10.1002/cbf.1558.

PMID:
19350537
15.

Fractional allele loss is a valuable marker for human lung cancer detection in sputum.

Arvanitis DA, Papadakis E, Zafiropoulos A, Spandidos DA.

Lung Cancer. 2003 Apr;40(1):55-66.

PMID:
12660007
16.

Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome.

Haataja R, Rämet M, Marttila R, Hallman M.

Hum Mol Genet. 2000 Nov 1;9(18):2751-60.

PMID:
11063734
17.

Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.

Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.

Lung Cancer. 2006 Apr;52(1):9-14. Epub 2006 Feb 24.

PMID:
16499995
18.

Genetic polymorphism of CYP2D6 and lung cancer risk.

Shaw GL, Falk RT, Frame JN, Weiffenbach B, Nesbitt JC, Pass HI, Caporaso NE, Moir DT, Tucker MA.

Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):215-9.

19.

Surfactant protein B gene variations and susceptibility to lung cancer in chromate workers.

Ewis AA, Kondo K, Dang F, Nakahori Y, Shinohara Y, Ishikawa M, Baba Y.

Am J Ind Med. 2006 May;49(5):367-73.

PMID:
16570259
20.

[Allelotyping the Hras1 minisatellite: formation of carcinogenic risk groups and predicting the course of non-small cell lung cancer].

Chizhikov VV, Gaspar'ian AV, Zborovskaia IB.

Genetika. 2001 Oct;37(10):1388-95. Russian.

PMID:
11761616

Supplemental Content

Support Center